multiple myeloma

money cash coins dollars

Biotech

Mountainfield, China's Keymed launch biotech with $180M series A

The new company, called Timberlyne Therapeutics, will be centered around the IgG1 monoclonal antibody CM313.

James Waldron Jan 10, 2025 8:43am

peeling an orange

Bristol Myers culls cell therapy deals with 2 biotechs

Dec 16, 2024 11:19am

Rendering of an immune cell

ASH: Gilead-Arcellx data build CAR-T's case in advanced myeloma

Nov 5, 2024 3:08pm

An imaginary winners podium is modelled and rendered

Trispecific antibody one-ups Tecvayli in myeloma mouse study

Sep 17, 2024 3:38pm

Graphic image of a red thumbs down against a blue background

FDA rejects Regeneron bispecific, delaying rival to J&J, Pfizer

Aug 21, 2024 5:48am

pivot change turnaround direction walk away

BMS axes bispecific months after filing to run phase 3 trial

Jul 26, 2024 8:17am